ArticleJournal of movement disorders2026
Opicapone for the Treatment of Nocturnal Hypokinesia in Patients With Parkinson's Disease: An Open-Label Pilot Clinical Trial.
Chaewon Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.